SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 31st, 2024 • Bluejay Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 31st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 31, 2024, between Bluejay Diagnostics, Inc., a Delaware corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
FORM OF SENIOR SECURED NOTE]Bluejay Diagnostics, Inc. • May 31st, 2024 • Surgical & medical instruments & apparatus • New York
Company FiledMay 31st, 2024 Industry JurisdictionTHIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. ANY TRANSFEREE OF THIS NOTE SHOULD CAREFULLY REVIEW THE TERMS OF THIS NOTE, INCLUDING SECTIONS 3(c)(iii) AND 18(a) HEREOF. THE PRINCIPAL AMOUNT REPRESENTED BY THIS NOTE
NOTE PURCHASE AGREEMENTNote Purchase Agreement • May 31st, 2024 • Bluejay Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 31st, 2024 Company Industry JurisdictionThis Note Purchase Agreement (this “Agreement”) is dated as of May 31, 2024, between Bluejay Diagnostics, Inc., a Delaware corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).